Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose–response data

Por Mpindi, John-Patrick, Swapnil, Potdar, Dmitrii, Bychkov, Jani, Saarela, Saeed, Khalid, Wennerberg, Krister, Aittokallio, Tero, Östling, Päivi, Kallioniemi, Olli
Publicado no Bioinformatics (2015)

Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment

Por Erlend Skaga, Evgeny Kulesskiy, Marit Brynjulvsen, Cecilie J. Sandberg, Swapnil Potdar, Iver A. Langmoen, Aki Laakso, Emília Gaál-Paavola, Markus Perola, Krister Wennerberg, Einar O. Vik-Mo
Publicado em 2019-12-01

Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma

Por Erlend Skaga, Evgeny Kulesskiy, Artem Fayzullin, Cecilie J. Sandberg, Swapnil Potdar, Aija Kyttälä, Iver A. Langmoen, Aki Laakso, Emília Gaál-Paavola, Markus Perola, Krister Wennerberg, Einar O. Vik-Mo
Publicado em 2019-06-01